Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Intestinal Bacterial Overgrowth Syndrome (SIBO)”

Showing 2 of 0 results

Not applicableUnknownNCT02565654
What this trial is testing

Efficacy of Rifaximin to Treat Diarrhea-predominant Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
First Affiliated Hospital, Sun Yat-Sen University 120
Post-approval studies (Phase 4)Not Yet RecruitingNCT07815548
What this trial is testing

Comparison of the Efficacy of Saccharomyces Boulardii and Rifaximin in the Treatment of Small Intestinal Bacterial Overgrowth

Who this might be right for
Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
Shandong University 222

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation